Neurotrope (NTRP) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free NTRP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsEarningsSocial MediaStock AnalysisCompetitorsEarningsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 18 at 7:12 PM | finance.yahoo.comNextTrip, Inc. (NTRP) Stock Price, News, Quote & History - Yahoo FinanceApril 30, 2024 | finance.yahoo.comNextTrip, Inc. (NTRP) Latest Stock News & Headlines - Yahoo FinanceApril 4, 2024 | morningstar.comNextTrip Inc NTRPMarch 14, 2024 | marketbeat.comTrading was temporarily halted for "NTRP" at 12:03 PM with a stated reason of "LULD pause."March 14, 2024 | marketbeat.comTrading was temporarily halted for "NTRP" at 12:03 PM with a stated reason of "LULD pause."March 14, 2024 | marketbeat.comTrading was temporarily halted for "NTRP" at 09:03 AM with a stated reason of "LULD pause."March 14, 2024 | marketbeat.comTrading was temporarily halted for "NTRP" at 09:03 AM with a stated reason of "LULD pause."March 13, 2024 | marketbeat.comTrading was temporarily halted for "NTRP" at 09:03 AM with a stated reason of "LULD pause."March 13, 2024 | marketbeat.comTrading was temporarily halted for "NTRP" at 09:03 AM with a stated reason of "LULD pause."August 17, 2023 | finance.yahoo.comAlzheimer's Disease Market Predicted to Surge at a CAGR of 20% During the Study Period (2019–2032), Assesses DelveInsightJune 22, 2022 | finance.yahoo.comAt 6.9% CAGR, Global Erectile Dysfunction Drugs Market Size & Share Will Hit US$ 5.94 Billion | Industry Trends, Demand, Growth, Value, Analysis & Forecast Report by Zion Market Research - Yahoo FinanceApril 7, 2022 | prnewswire.comVascular Dementia Market Is Contemplated to Surge at a CAGR of 4.05% in the 7MM for the Study Period of 2019-2032, Estimates DelveInsight - PR NewswireMarch 9, 2022 | radio.foxnews.comDr. Nicole Saphier On New Study That Finds Covid May Cause Changes In The Brain - FOX News RadioDecember 7, 2021 | seekingalpha.comPetros Pharmaceuticals: Advancing Complementary Men's Health Therapeutics - Seeking AlphaNovember 16, 2021 | marketscreener.comPETROS PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-Q) - marketscreener.comAugust 10, 2021 | nasdaq.comNeurotrope, Inc. Common Stock (NTRP)August 5, 2021 | prnewswire.comPrimary Hyperoxaluria Market Size Growth to Shore Up at a Substantial CAGR of 40.40% During the Study Period 2018-30 in the 7MM | DelveInsight - PRNewswire Get Neurotrope News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter. Email Address POTUS in ‘25 Not Biden/Trump, But (Ad)And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos. Click here now to see my urgent election warning. NTRP Media Mentions By Week NTRP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTRP News Sentiment▼0.000.57▲Average Consumer Discretionary News Sentiment NTRP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTRP Articles This Week▼10▲NTRP Articles Average Week Get Neurotrope News Delivered to You Automatically Sign up to receive the latest news and ratings for NTRP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Hempacco News Micromobility.com News Bon Natural Life News Interactive Strength News Safe & Green News SharpLink Gaming News China Liberal Education News Singing Machine News Gaxos.ai News Nova LifeStyle News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTRP) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersUrgent Nvidia WarningAltimetry41 banks launch ‘crypto dollar’Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neurotrope, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
